- $5.19bn
- $4.42bn
- $475.42m
- 99
- 22
- 89
- 79
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 27.42 | ||
| PEG Ratio (f) | 1.36 | ||
| EPS Growth (f) | 25.2% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 5.66 | ||
| Price to Tang. Book | 6.33 | ||
| Price to Free Cashflow | 28.62 | ||
| Price to Sales | 10.73 | ||
| EV to EBITDA | 24.92 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 17.58% | ||
| Return on Equity | 15.81% | ||
| Operating Margin | 34.47% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 116.39 | 206.9 | 343.55 | 419.05 | 475.42 | 512.3 | 558.66 | 40.87% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +1719.46 | +99.05 | +477.45 | -24.3 | +41.49 | +31.4 | +9.16 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Doximity, Inc. provides a digital platform for the United States medical professionals. It provides an online platform, which enables physicians and other healthcare professionals to collaborate with their colleagues, stay up to date with the latest medical news and research and manage their careers. It offers Marketing, Hiring, and Productivity Solutions to pharmaceutical manufacturers, health systems, medical recruiting firms, and certain other healthcare companies. Its Marketing Solutions enable its pharmaceutical and health system customers to get the right content, services, and peer connections to the right medical professionals through a variety of modules. Its Hiring Solutions provide digital recruiting capabilities to health systems and medical recruiting firms. Its Productivity Solutions include its telehealth, on-call scheduling, and artificial intelligence (AI)-supported medical correspondence tools and are designed to help clinicians streamline their clinical workflow.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- March 31st, 2024
- Incorporated
- April 16th, 2010
- Public Since
- June 24th, 2021
- No. of Shareholders
- 524
- No. of Employees
- 827
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
New York Stock Exchange- Shares in Issue
- 185,425,853
- Address
- 500 THIRD STREET, SAN FRANCISCO, 94107
- Web
- https://www.doximity.com/
- Phone
- +1 6505494330
- Auditors
- Deloitte & Touche LLP
Upcoming Events for DOCS
Q1 2025 Doximity Inc Earnings Release
Q2 2025 Doximity Inc Earnings Release
Similar to DOCS
A10 Networks
New York Stock Exchange
Accenture
New York Stock Exchange
Alibaba Holding
New York Stock Exchange
Alight
New York Stock Exchange
Allurion Technologies
New York Stock Exchange
FAQ
What is the Doximity share price?
As of Today at 20:21 UTC, shares in Doximity are trading at $27.52. This share price information is delayed by 15 minutes.
How has the Doximity share price performed this year?
Shares in Doximity last closed at $27.52 and the price had moved by -14.24% over the past 365 days. In terms of relative price strength the Doximity share price has underperformed the S&P500 Index by -31.76% over the past year.
What are the analyst and broker recommendations for Doximity?
The overall consensus recommendation for Doximity is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Doximity dividend yield?
Doximity does not currently pay a dividend.
Does Doximity pay a dividend?
Doximity does not currently pay a dividend.
When does Doximity next pay dividends?
Doximity does not currently pay a dividend.
How do I buy Doximity shares?
To buy shares in Doximity you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Doximity?
As of the previous close price of $27.52, shares in Doximity had a market capitalisation of $5.10bn.
Where are Doximity shares listed?
Here are the trading details for Doximity:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: DOCS
What kind of share is Doximity?
Based on an overall assessment of its quality, value and momentum Doximity is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Doximity share price forecast for 2024?
The analyst consensus target price for shares in Doximity is $29.92. That is 8.72% above the last closing price of $27.52.
Analysts covering Doximity currently have a consensus Earnings Per Share (EPS) forecast of $0.98 for the next financial year.
What is the trend in the Doximity share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Doximity. Over the past six months, its share price has underperformed the S&P500 Index by -13.88%.
As of the last closing price of $27.52, shares in Doximity were trading +7.22% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Doximity PE Ratio?
The Doximity PE ratio based on its reported earnings over the past 12 months is 27.42. The shares last closed at $27.52.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Doximity?
Doximity's management team is headed by:
- Jeffrey Tangney - CEO
- Shari Buck - CFD
- Nate Gross - CFD
- Anna Bryson - CFO
- Jey Balachandran - CTO